Collectively, our data suggest that PAX8 is a major TF in ovarian cancer cells by engaging a large number of genomic sites, while PRDM3 (MECOM) is specifically recruited by PAX8 at specific genomic loci to modulate a defined common gene module. The gene discussed is MECOM; the disease is ovarian carcinoma.